Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
about
Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable ResistanceFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSACommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicCombating antimicrobial resistance: policy recommendations to save livesCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciDevelopment of a vaccine against Staphylococcus aureusHost-pathogen interactions between the skin and Staphylococcus aureus.Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative StudiesAntimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responsesCharacterizing the network of drugs and their affected metabolic subpathwaysWhole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureusPanton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studiesTransmission of MRSA between companion animals and infected human patients presenting to outpatient medical care facilitiesThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Emergency ultrasound-assisted examination of skin and soft tissue infections in the pediatric emergency departmentPediatricians' perspectives on the impact of MRSA in primary care: a qualitative study.Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides.Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae using a modification of the finite supragenome modelTrends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.National athletic trainers' association position statement: skin diseases.Retrospective study of necrotizing fasciitis and characterization of its associated methicillin-resistant Staphylococcus aureus in Taiwan.Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United StatesMolecular typing and phenotype characterization of methicillin-resistant Staphylococcus aureus isolates from blood in TaiwanPeptide signaling in the staphylococci.The evolving role of chemical synthesis in antibacterial drug discovery.Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in miceRetapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.Does the nose know? An update on MRSA decolonization strategies.Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections.Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA cloneComparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletionMethicillin-resistant Staphylococcus aureus in HIV-infected patients.All purulence is local - epidemiology and management of skin and soft tissue infections in three urban emergency departments.Variable performance of models for predicting methicillin-resistant Staphylococcus aureus carriage in European surgical wards.Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins.Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach.Reliability of clinical examinations for pediatric skin and soft-tissue infectionsPatients with Panton-Valentine leukocidin positive Staphylococcus aureus infections run an increased risk of longer hospitalisation.
P2860
Q21089631-9ADD9157-70F3-4393-A890-04A5AF77507FQ22305769-F4B41746-B1F8-4AA6-AA00-C1BAD6B9B17EQ24614464-5C3489B7-23B4-438D-B02E-7ED59A0658CBQ24632857-0F5756C9-A9AC-4EEE-B268-D1914082CB5EQ26853465-D587225A-217D-4625-A8AC-BE5FBF767474Q27015365-C050D3E5-A1A1-49A6-9037-002BBFD8B00AQ27692552-750128B6-6B68-4A64-BAA9-AA3DEFBC6224Q28069555-79F48FB5-D7D3-4DE6-B8C1-FF8F182E882BQ28393128-21A93704-79BA-4A0F-A4B7-F1D0E0E42A77Q28474120-E4E038D7-BB56-4ECA-A5E5-7D967FE598A6Q28484558-4701E24C-E06D-40E8-9844-876D5A98FCCEQ28539903-E0F72E77-C86D-4438-ABB4-47E08D5EFA7AQ28729864-1702B226-3B3C-460A-90AD-304D1EE43FA4Q28742924-AA192A76-848F-497F-AAD6-C42749F8BFEAQ30415990-107DB98E-94E2-40E7-A12B-522432E86D0DQ30437403-556AAE7C-2825-425D-A5DB-517E4EEADE2AQ33430160-1020FB61-F5FB-4ED4-A99B-77CEC1CD5142Q33755855-526F3B5E-BF81-496C-8AA5-D6785E5817D5Q33871710-032C87A8-73B8-490F-9D03-27BB9BC34C7BQ33961776-72B650C7-B477-4326-AABE-64773A20DA9FQ33984713-21FE4BB0-0FCD-41E8-911B-E6FB0212A689Q34062840-4B01811A-F018-43E3-B006-84AB02886D10Q34108596-2C6D09CA-B040-44F8-AE36-1B29478CEE85Q34146036-14CBD927-8325-4012-B976-2025EE50D093Q34155983-2CDE6D4E-7233-450E-9A77-BABD071F988FQ34427652-FF780AD1-8398-456F-8960-B7C9430AB38DQ34499405-7176AC3F-A6B3-4B9E-834A-6393E26143D5Q34585413-0970FDAC-8839-45A0-A28D-511DDA125F38Q34649978-CC5FE8BE-2539-4252-9902-CCB42EEF4DB8Q34687434-53B8208A-6343-4479-B64A-7437C6653E02Q34700837-D74B1A13-4367-4F24-A555-AC6043E81F70Q34932588-B79BFFEA-A521-43DA-ABF2-95DA92406B1CQ35004978-8D7A0991-91B5-4474-94EF-E8F85C89755EQ35026548-9155174A-DAD5-481E-842C-9AA6DEC42815Q35073483-61429E0E-F0D6-403E-B844-D0EC77629C48Q35141215-F7F6C68E-65D3-4802-BA7B-C56E5C942BF1Q35164452-86485D8B-8FFB-431D-977E-801EA7241662Q35379738-479561A0-DCF9-4CA9-A798-D062720E7FD3Q35585040-4E475D85-AAE7-46DF-8311-FAF45C8FCC74Q35862697-C3080C09-AD19-4B43-ADFC-F73E4713525B
P2860
Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@ast
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@en
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@nl
type
label
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@ast
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@en
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@nl
prefLabel
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@ast
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@en
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@nl
P356
P1476
Clinical practice. Skin and so ...... sistant Staphylococcus aureus.
@en
P2093
Robert S Daum
P304
P356
10.1056/NEJMCP070747
P407
P577
2007-07-01T00:00:00Z